Recombinant growth hormone at supraphysiological doses reduces the occurrence of hypoglycemia by suppressing peripheral glucose uptake and stimulating gluconeogenesis and glycogenolysis [14,15]. This evidence concerns the gene GH1 and Hypoglycemia.